• ICH GCP
    • Dansk
    • Deutsch
    • English
    • Español
    • Français
    • Italiano
    • Magyar
    • Nederlands
    • Norsk
    • Polski
    • Português
    • Suomi
    • Svenska
    • Čeština
    • Русский
    • 日本語
    • 简体中文
    • 한국어
  • Regulations
    • USA (FDA)
    • UK (MHRA)
    • AUSTRALIA (NHMRC)
    • JAPAN (PMDA)
  • CRO List
  • Clinical Trials
    • US Clinical Trials Registry
    • EU Clinical Trials Registry
    • Pharmaceutical Companies
    • Clinical Research Labs
    • Clinical Research Events
    • Publications
    • Researchers
  • Jobs
  • Publications
  • News
  • Regulations
    • GLOBAL (ICH GCP)
    • USA (FDA)
    • UK (MHRA)
    • AUSTRALIA (NHMRC)
    • JAPAN (PMDA)
    • EU (EMA)
  • CRO List
  • Clinical Trials
    • US Clinical Trials Registry
    • EU Clinical Trials Registry
    • Pharmaceutical Companies
    • Clinical Research Labs
    • Service Companies
    • Clinical Research Events
    • Publications
    • Researchers
  • Jobs
  • Publications
  • News
Example: Heart Attack
  • Glossary
  • Understanding Clinical Trials

Search clinical trials for: Reflection

Total 118 results


  • NCT01989676
    Completed
    A Study Of PF-05280014 [Trastuzumab-Pfizer] Or Herceptin® [Trastuzumab-EU] Plus Paclitaxel In HER2 Positive First Line Metastatic Breast Cancer Treatment (REFLECTIONS B327-02)
    Metastatic Breast Cancer
  • NCT02213263
    Completed
    A Study Of PF-05280586 (Rituximab-Pfizer) Or MabThera® (Rituximab-EU) For The First-Line Treatment Of Patients With CD20-Positive, Low Tumor Burden, Follicular Lymphoma (REFLECTIONS B328-06)
    Follicular Lymphoma
  • NCT02480153
    Completed
    A Study Of PF-06410293 (Adalimumab-Pfizer) And Adalimumab (Humira®) In Combination With Methotrexate In Subjects With Active Rheumatoid Arthritis (REFLECTIONS B538-02).
    Rheumatoid Arthritis
  • NCT02187744
    Completed
    A Study Of PF-05280014 Or Trastuzumab Plus Taxotere® And Carboplatin In HER2 Positive Breast Cancer In The Neoadjuvant Setting (REFLECTIONS B327-04)
    Early Breast Cancer
  • NCT02222493
    Completed
    A Study of PF-06438179 (Infliximab-Pfizer) and Infliximab in Combination With Methotrexate in Subjects With Active Rheumatoid Arthritis (REFLECTIONS B537-02).
    Rheumatoid Arthritis

This is a preview
Log in or create a free account to see all matching trials and use the full search.
Log in | Register

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.

«Manage Settings
Regulations
  • GLOBAL (ICH GCP)
  • USA (FDA)
  • UK (MHRA)
  • AUSTRALIA (NHMRC)
  • JAPAN (PMDA)
  • EU (EMA)
Resources
  • CRO List
  • Pharmaceutical Companies
  • Clinical Research Labs
  • Service Companies
  • Jobs
  • US Clinical Trials Registry
  • EU Clinical Trials Registry
Articles
  • Publications
  • News
  • About us / Our mission
Language
Dansk Deutsch English Español Français Italiano Magyar Nederlands Norsk Polski Português Suomi Svenska Čeština Русский 日本語 简体中文 한국어
  • Sitemap
  • Contact us
  • RSS feed
  • Privacy Policy
  • Disclaimer
© ICH GCP. All Rights Reserved.